R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD technology, which is designed to assist radiologists in the early detection of breast cancer and has already been incorporated into digital mammography systems from other vendors, including GE Medical Systems. The two companies plan to integrate CAD not only into the MicroDose mammography system but also into Sectra PACS for Breast Imaging. Under the agreement, Sectra will have exclusive worldwide distribution rights for three years to R2's CAD technology as applied to Sectra's MicroDose mammography system. The system is based on a highly efficient digital detector technology, which promises to reduce radiation dose by 80% or more without affecting image quality. Sectra recently invested more than $11 million in Stockholm-based Mamea Imaging, developer of the novel detector technology and ergonomic imaging stand that make up Sectra's low-dose digital mammography system (SCAN 1/8/04).
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.